Kintara Therapeutics Balance Sheet Health
Financial Health criteria checks 3/6
Kintara Therapeutics has a total shareholder equity of $-164.0K and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $1.9M and $2.0M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$772.00k |
| Equity | -US$164.00k |
| Total liabilities | US$2.05m |
| Total assets | US$1.89m |
Recent financial health updates
Recent updates
Kintara soars 66% on pausing breast cancer study, to use cash for brain cancer trial
Oct 19Kintara Therapeutics GAAP EPS of -$0.52
Sep 27Kintara Therapeutics rallies after $20M stock purchase deal with Lincoln Park Capital Fund
Aug 03Kintara Therapeutics (NASDAQ:KTRA) Will Have To Spend Its Cash Wisely
Apr 12
Kintara Therapeutics shares rise on mid-stage glioblastoma trial update
May 26Kintara initiates recruitment for VAL-083's study arm in the GBM AGILE trial
Jan 13Kintara Therapeutics reports VAL-083 interim data for the treatment of glioblastoma multiforme
Nov 19Financial Position Analysis
Short Term Liabilities: KTRA has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: KTRA has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: KTRA is debt free.
Reducing Debt: KTRA's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: KTRA has sufficient cash runway for 1 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: KTRA is forecast to have sufficient cash runway for 1 months based on free cash flow estimates, but has since raised additional capital.